HPS Pharmacies wish to give notice that Juno Pharmaceuticals is experiencing a supply interruption for suxamethonium ampoules as follows:
AstraZeneca Suxamethonium Chloride
Suxamethonium chloride 100mg/2mL
Normal supplies are expected to resume in mid-August 2020. An internationally registered brand of suxamethonium chloride 50mg/mL (2mL ampoules) has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that Section 19A alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Juno Pharmaceuticals on (03) 8888 1288 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates